{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:20:00Z","timestamp":1793388000023,"version":"4.5.0"},"reference-count":272,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12035-025-05210-y","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T02:58:18Z","timestamp":1752893898000},"page":"15450-15477","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Neurochemical Insights into the Role of Tryptophan Metabolites and Kynurenine Pathway in Insomnia and its Psychological and Neurological Comorbidities"],"prefix":"10.1007","volume":"62","author":[{"given":"Wedad S.","family":"Sarawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"issue":"3","key":"5210_CR1","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1152\/physrev.00010.2018","volume":"99","author":"L Besedovsky","year":"2019","unstructured":"Besedovsky L, Lange T, Haack M (2019) The sleep-immune crosstalk in health and disease. Physiological reviews 99(3):1325\u20131380","journal-title":"Physiol Rev"},{"key":"5210_CR2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.conb.2017.05.001","volume":"44","author":"R Boyce","year":"2017","unstructured":"Boyce R, Williams S, Adamantidis A (2017) REM sleep and memory. Curr Opin Neurobiol 44:167\u2013177","journal-title":"Curr Opin Neurobiol"},{"issue":"5","key":"5210_CR3","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/cercor\/bhn155","volume":"19","author":"M Nishida","year":"2009","unstructured":"Nishida M et al (2009) REM sleep, prefrontal theta, and the consolidation of human emotional memory. Cereb Cortex 19(5):1158\u201366","journal-title":"Cereb Cortex"},{"issue":"2","key":"5210_CR4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nn.3303","volume":"16","author":"R Stickgold","year":"2013","unstructured":"Stickgold R, Walker MP (2013) Sleep-dependent memory triage: evolving generalization through selective processing. Nat Neurosci 16(2):139\u201345","journal-title":"Nat Neurosci"},{"issue":"1","key":"5210_CR5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuron.2013.12.025","volume":"81","author":"G Tononi","year":"2014","unstructured":"Tononi G, Cirelli C (2014) Sleep and the price of plasticity: from synaptic and cellular homeostasis to memory consolidation and integration. Neuron 81(1):12\u201334","journal-title":"Neuron"},{"issue":"5","key":"5210_CR6","first-page":"490","volume":"117","author":"P Tatineny","year":"2020","unstructured":"Tatineny P et al (2020) Sleep in the elderly. Mo Med 117(5):490\u2013495","journal-title":"Mo Med"},{"key":"5210_CR7","doi-asserted-by":"crossref","unstructured":"Lin LY et al (2020) The immediate impact of the 2019 novel coronavirus (COVID-19) outbreak on subjective sleep status. Sleep Med 77:348\u2013354","DOI":"10.1016\/j.sleep.2020.05.018"},{"key":"5210_CR8","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1177\/10547738221112748","volume":"31","author":"A \u00c7evik","year":"2022","unstructured":"\u00c7evik A et al (2022) Effects of the Covid-19 pandemic on the prevalence of insomnia, anxiety, and depression during pregnancy: a systematic review and meta-analysis. Clinical Nursing Research 31:1405\u20131421","journal-title":"Clin Nurs Res"},{"issue":"5","key":"5210_CR9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","volume":"8","author":"M Taquet","year":"2021","unstructured":"Taquet M et al (2021) 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. The Lancet Psychiatry 8(5):416\u2013427","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"5210_CR10","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.neubiorev.2009.03.002","volume":"33","author":"FG Revel","year":"2009","unstructured":"Revel FG et al (2009) Rodent models of insomnia: a review of experimental procedures that induce sleep disturbances. Neurosci Biobehav Rev 33(6):874\u201399","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"5210_CR11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s41782-019-00066-4","volume":"3","author":"S Abdulahad","year":"2019","unstructured":"Abdulahad S et al (2019) Irritable bowel syndrome, immune fitness, and insomnia: results from an online survey among people reporting sleep complaints. Sleep and Vigilance 3(2):121\u2013129","journal-title":"Sleep Vigilance"},{"key":"5210_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychores.2017.05.016","volume":"99","author":"HJ Cho","year":"2017","unstructured":"Cho HJ et al (2017) Sleep disturbance and kynurenine metabolism in depression. Journal of Psychosomatic Research 99:1\u20137","journal-title":"J Psychosom Res"},{"issue":"4","key":"5210_CR13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/da.10151","volume":"18","author":"CL Drake","year":"2003","unstructured":"Drake CL, Roehrs T, Roth T (2003) Insomnia causes, consequences, and therapeutics: an overview. Depress Anxiety 18(4):163\u201376","journal-title":"Depress Anxiety"},{"issue":"5","key":"5210_CR14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/HCO.0000000000000324","volume":"31","author":"MA Grandner","year":"2016","unstructured":"Grandner MA et al (2016) Sleep: important considerations for the prevention of cardiovascular disease. Curr Opin Cardiol 31(5):551\u201365","journal-title":"Curr Opin Cardiol"},{"issue":"4 Suppl","key":"5210_CR15","first-page":"S76","volume":"26","author":"JA Dopheide","year":"2020","unstructured":"Dopheide JA (2020) Insomnia overview: epidemiology, pathophysiology, diagnosis and monitoring, and nonpharmacologic therapy. Am J Manag Care 26(4 Suppl):S76-s84","journal-title":"Am J Manag Care"},{"issue":"1","key":"5210_CR16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/NDT.S483","volume":"4","author":"DN Neubauer","year":"2008","unstructured":"Neubauer DN (2008) A review of ramelteon in the treatment of sleep disorders. Neuropsychiatric disease and treatment 4(1):69\u201379","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"5210_CR17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1474-4422(21)00436-1","volume":"21","author":"E Mignot","year":"2022","unstructured":"Mignot E et al (2022) Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials. Lancet Neurol 21(2):125\u2013139","journal-title":"Lancet Neurol"},{"key":"5210_CR18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40263-023-00987-9","volume":"37","author":"T Nie","year":"2023","unstructured":"Nie T, Blair HA (2023) Daridorexant in insomnia disorder: a profile of its use. CNS Drugs 37:267\u2013274","journal-title":"CNS Drugs"},{"issue":"4","key":"5210_CR19","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1378\/chest.14-1617","volume":"147","author":"JC Levenson","year":"2015","unstructured":"Levenson JC, Kay DB, Buysse DJ (2015) The pathophysiology of insomnia. Chest 147(4):1179\u20131192","journal-title":"Chest"},{"key":"5210_CR20","first-page":"591729","volume":"2015","author":"TW Kim","year":"2015","unstructured":"Kim TW, Jeong JH, Hong SC (2015) The impact of sleep and circadian disturbance on hormones and metabolism. Int J Endocrinol 2015:591729","journal-title":"Int J Endocrinol"},{"issue":"2","key":"5210_CR21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.13078\/jsm.240014","volume":"21","author":"N Khara","year":"2024","unstructured":"Khara N et al (2024) The intricacies of insomnia: a comprehensive exploration. J Sleep Med 21(2):65\u201372","journal-title":"J Sleep Med"},{"issue":"1","key":"5210_CR22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.smrv.2006.06.002","volume":"11","author":"T Roth","year":"2007","unstructured":"Roth T, Roehrs T, Pies R (2007) Insomnia: pathophysiology and implications for treatment. Sleep Med Rev 11(1):71\u20139","journal-title":"Sleep Med Rev"},{"issue":"3","key":"5210_CR23","first-page":"359","volume":"17","author":"MR Irwin","year":"2018","unstructured":"Irwin MR, Piber D (2018) Insomnia and inflammation: a two hit model of depression risk and prevention. World psychiatry\u202f: official journal of the World Psychiatric Association (WPA) 17(3):359\u2013361","journal-title":"World Psychiatry Off J World Psychiatric Assoc (WPA)"},{"issue":"1","key":"5210_CR24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/npp.2016.148","volume":"42","author":"MR Irwin","year":"2017","unstructured":"Irwin MR, Opp MR (2017) Sleep health: reciprocal regulation of sleep and innate immunity. Neuropsychopharmacology 42(1):129\u2013155","journal-title":"Neuropsychopharmacology"},{"key":"5210_CR25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2015.01.004","volume":"47","author":"KP Wright Jr","year":"2015","unstructured":"Wright KP Jr et al (2015) Influence of sleep deprivation and circadian misalignment on cortisol, inflammatory markers, and cytokine balance. Brain Behav Immun 47:24\u201334","journal-title":"Brain Behav Immun"},{"key":"5210_CR26","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.3389\/fimmu.2019.02565","volume":"10","author":"FJH Sorgdrager","year":"2019","unstructured":"Sorgdrager FJH et al (2019) Tryptophan metabolism in inflammaging: from biomarker to therapeutic target. Front Immunol 10:2565","journal-title":"Front Immunol"},{"key":"5210_CR27","doi-asserted-by":"crossref","unstructured":"Jenkins TA et al (2016) Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis. Nutrients 8(1):56","DOI":"10.3390\/nu8010056"},{"key":"5210_CR28","doi-asserted-by":"crossref","unstructured":"Sas K, E Szabo, Vecsei L (2018) Mitochondria, oxidative stress and the kynurenine system, with a focus on ageing and neuroprotection. Molecules 23(1):191","DOI":"10.3390\/molecules23010191"},{"key":"5210_CR29","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3389\/fnins.2019.01013","volume":"13","author":"VX Tan","year":"2019","unstructured":"Tan VX, Guillemin GJ (2019) Kynurenine pathway metabolites as biomarkers for amyotrophic lateral sclerosis. Front Neurosci 13:1013","journal-title":"Front Neurosci"},{"key":"5210_CR30","doi-asserted-by":"crossref","first-page":"1002004","DOI":"10.3389\/fnins.2022.1002004","volume":"16","author":"TW Stone","year":"2022","unstructured":"Stone TW et al (2022) An integrated cytokine and kynurenine network as the basis of neuroimmune communication. Front Neurosci 16:1002004","journal-title":"Front Neurosci"},{"key":"5210_CR31","doi-asserted-by":"crossref","unstructured":"Pocivavsek A et al (2017)\u00a0Acute kynurenine challenge disrupts sleep-wake architecture and impairs contextual memory in adult rats. Sleep\u00a040(11):zsx141","DOI":"10.1093\/sleep\/zsx141"},{"issue":"6","key":"5210_CR32","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbi.2012.05.010","volume":"26","author":"MM Hughes","year":"2012","unstructured":"Hughes MM et al (2012) Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation. Brain Behav Immun 26(6):979\u201387","journal-title":"Brain Behav Immun"},{"issue":"18","key":"5210_CR33","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.4155\/bio-2016-0111","volume":"8","author":"R Fuertig","year":"2016","unstructured":"Fuertig R et al (2016) LC-MS\/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain. Bioanalysis 8(18):1903\u201317","journal-title":"Bioanalysis"},{"issue":"1","key":"5210_CR34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000496293","volume":"79","author":"JM Gostner","year":"2020","unstructured":"Gostner JM et al (2020) Tryptophan metabolism and related pathways in psychoneuroimmunology: The Impact of Nutrition and Lifestyle. Neuropsychobiology 79(1):89\u201399","journal-title":"Neuropsychobiology"},{"key":"5210_CR35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.psyneuen.2018.05.019","volume":"95","author":"K Doolin","year":"2018","unstructured":"Doolin K et al (2018) Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes. Psychoneuroendocrinology 95:8\u201317","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"5210_CR36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00702-011-0685-7","volume":"119","author":"V Gabbay","year":"2012","unstructured":"Gabbay V et al (2012) The possible role of the kynurenine pathway in anhedonia in adolescents. J Neural Transm (Vienna) 119(2):253\u201360","journal-title":"J Neural Transm (Vienna)"},{"issue":"9","key":"5210_CR37","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/0269881117711708","volume":"31","author":"P Kopschina Feltes","year":"2017","unstructured":"Kopschina Feltes P et al (2017) Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy. J Psychopharmacol 31(9):1149\u20131165","journal-title":"J Psychopharmacol"},{"key":"5210_CR38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbi.2019.10.017","volume":"83","author":"E Achtyes","year":"2020","unstructured":"Achtyes E et al (2020) Inflammation and kynurenine pathway dysregulation in post-partum women with severe and suicidal depression. Brain Behav Immun 83:239\u2013247","journal-title":"Brain Behav Immun"},{"key":"5210_CR39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4615-0135-0_12","volume":"527","author":"GJ Guillemin","year":"2003","unstructured":"Guillemin GJ et al (2003) Expression of the kynurenine pathway enzymes in human microglia and macrophages. Adv Exp Med Biol 527:105\u201312","journal-title":"Adv Exp Med Biol"},{"key":"5210_CR40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2017.07.008","volume":"810","author":"K O'Farrell","year":"2017","unstructured":"O\u2019Farrell K et al (2017) Inhibition of the kynurenine pathway protects against reactive microglial-associated reductions in the complexity of primary cortical neurons. Eur J Pharmacol 810:163\u2013173","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"5210_CR41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/bdi.12529","volume":"20","author":"D Mukherjee","year":"2018","unstructured":"Mukherjee D et al (2018) Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder. Bipolar disorders 20(1):27\u201334","journal-title":"Bipolar disorders"},{"key":"5210_CR42","doi-asserted-by":"crossref","first-page":"769501","DOI":"10.3389\/fphar.2021.769501","volume":"12","author":"X Li","year":"2021","unstructured":"Li X et al (2021) New insights into gut-bacteria-derived indole and its derivatives in intestinal and liver diseases. Front Pharmacol 12:769501","journal-title":"Front Pharmacol"},{"key":"5210_CR43","doi-asserted-by":"crossref","unstructured":"Hou Y, Li J, Ying S (2023) Tryptophan metabolism and gut microbiota: a novel regulatory axis integrating the microbiome, immunity, and cancer. Metabolites 13(11):1166","DOI":"10.3390\/metabo13111166"},{"issue":"1","key":"5210_CR44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/joim.12892","volume":"286","author":"T Hendrikx","year":"2019","unstructured":"Hendrikx T, Schnabl B (2019) Indoles: metabolites produced by intestinal bacteria capable of controlling liver disease manifestation. J Intern Med 286(1):32\u201340","journal-title":"J Intern Med"},{"issue":"1","key":"5210_CR45","doi-asserted-by":"crossref","first-page":"21011","DOI":"10.1038\/s41598-021-99845-1","volume":"11","author":"CR Brydges","year":"2021","unstructured":"Brydges CR et al (2021) Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature. Sci Rep 11(1):21011","journal-title":"Sci Rep"},{"issue":"2","key":"5210_CR46","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/nutrit\/nuab027","volume":"80","author":"CN Sutanto","year":"2022","unstructured":"Sutanto CN, Loh WW, Kim JE (2022) The impact of tryptophan supplementation on sleep quality: a systematic review, meta-analysis, and meta-regression. Nutr Rev 80(2):306\u2013316","journal-title":"Nutr Rev"},{"issue":"8","key":"5210_CR47","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1177\/0269881119855978","volume":"33","author":"JH van Dalfsen","year":"2019","unstructured":"van Dalfsen JH, Markus CR (2019) The serotonin transporter gene-linked polymorphic region (5-HTTLPR) and the sleep-promoting effects of tryptophan: a randomized placebo-controlled crossover study. J Psychopharmacol 33(8):948\u2013954","journal-title":"J Psychopharmacol"},{"issue":"3","key":"5210_CR48","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neubiorev.2009.08.005","volume":"34","author":"BY Silber","year":"2010","unstructured":"Silber BY, Schmitt JAJ (2010) Effects of tryptophan loading on human cognition, mood, and sleep. Neuroscience & Biobehavioral Reviews 34(3):387\u2013407","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"5210_CR49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/10284150500069561","volume":"8","author":"C Hudson","year":"2005","unstructured":"Hudson C et al (2005) Protein source tryptophan versus pharmaceutical grade tryptophan as an efficacious treatment for chronic insomnia. Nutr Neurosci 8(2):121\u20137","journal-title":"Nutr Neurosci"},{"issue":"2","key":"5210_CR50","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbr.2003.10.018","volume":"152","author":"J Minet-Ringuet","year":"2004","unstructured":"Minet-Ringuet J et al (2004) A tryptophan-rich protein diet efficiently restores sleep after food deprivation in the rat. Behav Brain Res 152(2):335\u201340","journal-title":"Behav Brain Res"},{"issue":"5","key":"5210_CR51","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0893-133X(02)00358-5","volume":"27","author":"I Arnulf","year":"2002","unstructured":"Arnulf I et al (2002) Mid-morning tryptophan depletion delays REM sleep onset in healthy subjects. Neuropsychopharmacology 27(5):843\u201351","journal-title":"Neuropsychopharmacology"},{"issue":"29","key":"5210_CR52","doi-asserted-by":"crossref","first-page":"10761","DOI":"10.1073\/pnas.1402663111","volume":"111","author":"SK Davies","year":"2014","unstructured":"Davies SK et al (2014) Effect of sleep deprivation on the human metabolome. Proc Natl Acad Sci U S A 111(29):10761\u20136","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5210_CR53","doi-asserted-by":"crossref","unstructured":"Chojnacki C et al (2023) Beneficial effect of increased tryptophan intake on its metabolism and mental state of the elderly. Nutrients 15(4):847","DOI":"10.3390\/nu15040847"},{"issue":"6","key":"5210_CR54","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/ajcn\/71.6.1536","volume":"71","author":"CR Markus","year":"2000","unstructured":"Markus CR et al (2000) The bovine protein alpha-lactalbumin increases the plasma ratio of tryptophan to the other large neutral amino acids, and in vulnerable subjects raises brain serotonin activity, reduces cortisol concentration, and improves mood under stress. Am J Clin Nutr 71(6):1536\u201344","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"5210_CR55","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/ajcn\/75.6.1051","volume":"75","author":"CR Markus","year":"2002","unstructured":"Markus CR, Olivier B, de Haan EH (2002) Whey protein rich in alpha-lactalbumin increases the ratio of plasma tryptophan to the sum of the other large neutral amino acids and improves cognitive performance in stress-vulnerable subjects. Am J Clin Nutr 75(6):1051\u20136","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"5210_CR56","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/ajcn\/81.5.1026","volume":"81","author":"CR Markus","year":"2005","unstructured":"Markus CR et al (2005) Evening intake of alpha-lactalbumin increases plasma tryptophan availability and improves morning alertness and brain measures of attention. Am J Clin Nutr 81(5):1026\u201333","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"5210_CR57","first-page":"271","volume":"3","author":"TC Birdsall","year":"1998","unstructured":"Birdsall TC (1998) 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Alternative medicine review\u202f: a journal of clinical therapeutic 3(4):271\u201380","journal-title":"Altern Med Rev J Clin Ther"},{"issue":"1","key":"5210_CR58","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/sleep\/8.1.56","volume":"8","author":"F Petitjean","year":"1985","unstructured":"Petitjean F et al (1985) Insomnia caused by administration of para-chlorophenylalanine: reversibility by peripheral or central injection of 5-hydroxytryptophan and serotonin. Sleep 8(1):56\u201367","journal-title":"Sleep"},{"issue":"2","key":"5210_CR59","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0306-4522(99)00435-2","volume":"95","author":"L Imeri","year":"2000","unstructured":"Imeri L et al (2000) 5-Hydroxytryptophan, but not L-tryptophan, alters sleep and brain temperature in rats. Neuroscience 95(2):445\u201352","journal-title":"Neuroscience"},{"issue":"1","key":"5210_CR60","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00231046","volume":"86","author":"M Touret","year":"1991","unstructured":"Touret M et al (1991) The role of 5-hydroxytryptophan (5-HTP) in the regulation of the sleep\/wake cycle in parachlorophenylalanine (p-CPA) pretreated rat: a multiple approach study. Exp Brain Res 86(1):117\u201324","journal-title":"Exp Brain Res"},{"issue":"1","key":"5210_CR61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/sleep\/31.1.21","volume":"31","author":"JD Morrow","year":"2008","unstructured":"Morrow JD et al (2008) Effects of serotonergic activation by 5-hydroxytryptophan on sleep and body temperature of C57BL\/6J and interleukin-6-deficient mice are dose and time related. Sleep 31(1):21\u201333","journal-title":"Sleep"},{"issue":"4","key":"5210_CR62","doi-asserted-by":"crossref","first-page":"R1116","DOI":"10.1152\/ajpregu.00074.2005","volume":"289","author":"L Imeri","year":"2005","unstructured":"Imeri L, Bianchi S, Opp MR (2005) Antagonism of corticotropin-releasing hormone alters serotonergic-induced changes in brain temperature, but not sleep, of rats. Am J Physiol Regul Integr Comp Physiol 289(4):R1116-23","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"5210_CR63","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4162\/nrp.2018.12.3.208","volume":"12","author":"KB Hong","year":"2018","unstructured":"Hong KB, Park Y, Suh HJ (2018) Two combined amino acids promote sleep activity in caffeine-induced sleepless model systems. Nutr Res Pract 12(3):208\u2013214","journal-title":"Nutr Res Pract"},{"key":"5210_CR64","doi-asserted-by":"crossref","unstructured":"Sutanto CN et al (2021) The impact of 5-hydroxytryptophan supplementation on sleep quality of older adults in Singapore: a randomized controlled trial. Curr Dev Nutr 43(3):593\u2013602","DOI":"10.1016\/j.clnu.2024.01.010"},{"issue":"3","key":"5210_CR65","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s11325-021-02417-w","volume":"26","author":"M Meloni","year":"2022","unstructured":"Meloni M et al (2022) Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson\u2019s disease. Sleep Breath 26(3):1023\u20131031","journal-title":"Sleep Breath"},{"issue":"1","key":"5210_CR66","doi-asserted-by":"crossref","first-page":"14","DOI":"10.33069\/cim.2018.0005","volume":"1","author":"J Lee","year":"2019","unstructured":"Lee J, Choo H (2019) Serotonin receptors for treatment of insomnia. Chronobiol Med 1(1):14\u201320","journal-title":"Chronobiol Med"},{"issue":"12","key":"5210_CR67","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.5665\/sleep.5256","volume":"38","author":"NM Murray","year":"2015","unstructured":"Murray NM, Buchanan GF, Richerson GB (2015) Insomnia caused by serotonin depletion is due to hypothermia. Sleep 38(12):1985\u201393","journal-title":"Sleep"},{"key":"5210_CR68","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0079-6123(08)00929-1","volume":"172","author":"JM Monti","year":"2008","unstructured":"Monti JM, Jantos H (2008) The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. Prog Brain Res 172:625\u201346","journal-title":"Prog Brain Res"},{"issue":"4","key":"5210_CR69","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.smrv.2010.11.003","volume":"15","author":"JM Monti","year":"2011","unstructured":"Monti JM (2011) Serotonin control of sleep-wake behavior. Sleep Med Rev 15(4):269\u201381","journal-title":"Sleep Med Rev"},{"issue":"7","key":"5210_CR70","doi-asserted-by":"crossref","first-page":"989","DOI":"10.5664\/jcsm.5932","volume":"12","author":"N Aarts","year":"2016","unstructured":"Aarts N et al (2016) Use of selective serotonin reuptake inhibitors and sleep quality: a population-based study. J Clin Sleep Med 12(7):989\u201395","journal-title":"J Clin Sleep Med"},{"issue":"7\u20138","key":"5210_CR71","first-page":"20","volume":"10","author":"RA Sansone","year":"2013","unstructured":"Sansone RA, Sansone LA (2013) Sunshine, serotonin, and skin: a partial explanation for seasonal patterns in psychopathology? Innov Clin Neurosci 10(7\u20138):20\u20134","journal-title":"Innov Clin Neurosci"},{"key":"5210_CR72","doi-asserted-by":"crossref","unstructured":"Sochal M et al (2023) The effect of serotonin transmission on depressive and insomnia symptoms in inflammatory bowel diseases. J Clin Med 12(19):6353","DOI":"10.3390\/jcm12196353"},{"issue":"1","key":"5210_CR73","doi-asserted-by":"crossref","first-page":"78","DOI":"10.24869\/psyd.2019.78","volume":"31","author":"Z Kovacic Petrovic","year":"2019","unstructured":"Kovacic Petrovic Z et al (2019) The association between serotonin transporter polymorphism, platelet serotonin concentration and insomnia in non-depressed veterans with posttraumatic stress disorder. Psychiatr Danub 31(1):78\u201387","journal-title":"Psychiatr Danub"},{"issue":"1","key":"5210_CR74","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/jpet.109.160994","volume":"332","author":"HA Al-Shamma","year":"2010","unstructured":"Al-Shamma HA et al (2010) Nelotanserin, a novel selective human 5-hydroxytryptamine2a inverse agonist for the treatment of insomnia. The Journal of Pharmacology and Experimental Therapeutics 332(1):281\u2013290","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"5210_CR75","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1021\/jm9007328","volume":"53","author":"BR Teegarden","year":"2010","unstructured":"Teegarden BR et al (2010) Discovery of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea (nelotanserin) and related 5-hydroxytryptamine2A inverse agonists for the treatment of insomnia. J Med Chem 53(5):1923\u201336","journal-title":"J Med Chem"},{"issue":"6","key":"5210_CR76","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1248\/bpb.b14-00887","volume":"38","author":"R Tsutsui","year":"2015","unstructured":"Tsutsui R et al (2015) Effects of the 5-HT(1A) Receptor agonist tandospirone on ACTH-induced sleep disturbance in rats. Biol Pharm Bull 38(6):884\u20138","journal-title":"Biol Pharm Bull"},{"key":"5210_CR77","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fnmol.2017.00152","volume":"10","author":"E Murillo-Rodr\u00edguez","year":"2017","unstructured":"Murillo-Rodr\u00edguez E et al (2017) Role of N-arachidonoyl-serotonin (AA-5-HT) in sleep-wake cycle architecture, sleep homeostasis, and neurotransmitters regulation. Front Mol Neurosci 10:152","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"5210_CR78","doi-asserted-by":"crossref","first-page":"206","DOI":"10.32794\/mr11250091","volume":"4","author":"SR Pandi-Perumal","year":"2021","unstructured":"Pandi-Perumal SR, Brown GM, Cardinali DP (2021) An urgent proposal for the immediate use of melatonin as an adjuvant to anti- SARS-CoV-2 vaccination. Melatonin Research 4(1):206\u2013212","journal-title":"Melatonin Res"},{"issue":"5","key":"5210_CR79","first-page":"349","volume":"55","author":"E Holvoet","year":"2013","unstructured":"Holvoet E, Gabri\u00ebls L (2013) Disturbed sleep in children with ADHD: is there a place for melatonin as a treatment option? Tijdschr Psychiatr 55(5):349\u201357","journal-title":"Tijdschr Psychiatr"},{"key":"5210_CR80","doi-asserted-by":"crossref","unstructured":"Rzepka-Migut B, Paprocka J (2020) Efficacy and safety of melatonin treatment in children with autism spectrum disorder and attention-deficit\/hyperactivity disorder-a review of the literature. Brain Sci 10(4):219","DOI":"10.3390\/brainsci10040219"},{"issue":"2\u20133","key":"5210_CR81","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.physbeh.2006.09.001","volume":"90","author":"Y Touitou","year":"2007","unstructured":"Touitou Y, Bogdan A (2007) Promoting adjustment of the sleep-wake cycle by chronobiotics. Physiol Behav 90(2\u20133):294\u2013300","journal-title":"Physiol Behav"},{"issue":"3","key":"5210_CR82","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-079X.2010.00844.x","volume":"50","author":"JE Jan","year":"2011","unstructured":"Jan JE et al (2011) Melatonin has membrane receptor-independent hypnotic action on neurons: an hypothesis. J Pineal Res 50(3):233\u201340","journal-title":"J Pineal Res"},{"issue":"9","key":"5210_CR83","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2826.2007.01574.x","volume":"19","author":"AN Inyushkin","year":"2007","unstructured":"Inyushkin AN et al (2007) Melatonin modulates spike coding in the rat suprachiasmatic nucleus. J Neuroendocrinol 19(9):671\u201381","journal-title":"J Neuroendocrinol"},{"issue":"4","key":"5210_CR84","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-079X.2011.00962.x","volume":"52","author":"DP Cardinali","year":"2012","unstructured":"Cardinali DP et al (2012) Melatonin and its analogs in insomnia and depression. Journal of Pineal Research 52(4):365\u2013375","journal-title":"J Pineal Res"},{"issue":"1","key":"5210_CR85","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1365-2869.1999.00130.x","volume":"8","author":"K Lushington","year":"1999","unstructured":"Lushington K et al (1999) The relationship between 6-sulphatoxymelatonin and polysomnographic sleep in good sleeping controls and wake maintenance insomniacs, aged 55\u201380 years. J Sleep Res 8(1):57\u201364","journal-title":"J Sleep Res"},{"issue":"2","key":"5210_CR86","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.amjmed.2003.07.017","volume":"116","author":"D Leger","year":"2004","unstructured":"Leger D, Laudon M, Zisapel N (2004) Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy. Am J Med 116(2):91\u20135","journal-title":"Am J Med"},{"issue":"6","key":"5210_CR87","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/01616412.2017.1315864","volume":"39","author":"Z Xie","year":"2017","unstructured":"Xie Z et al (2017) A review of sleep disorders and melatonin. Neurol Res 39(6):559\u2013565","journal-title":"Neurol Res"},{"key":"5210_CR88","doi-asserted-by":"crossref","unstructured":"Ukraintseva YV et al (2020)\u00a0Selective slow-wave sleep suppression affects glucose tolerance and melatonin secretion. The role of sleep architecture. Sleep Med\u00a067:171-183","DOI":"10.1016\/j.sleep.2019.11.1254"},{"key":"5210_CR89","doi-asserted-by":"crossref","unstructured":"Ukraintseva YV, Saltykov KA (2024)\u00a0Effects of slow-wave sleep fragmentation and rapid eye movement sleep fragmentation on melatonin secretion. Zh Nevrol Psikhiatr Im S S Korsakova\u00a0124(5. Vyp. 2):26-32","DOI":"10.17116\/jnevro202412405226"},{"issue":"1","key":"5210_CR90","doi-asserted-by":"crossref","first-page":"51","DOI":"10.18295\/2075-0528.2619","volume":"6","author":"S Kassab","year":"2006","unstructured":"Kassab S et al (2006) Cardiovascular responses to tonic pain in REM sleep-deprived rats: role of melatonin and beta endorphin. Sultan Qaboos Univ Med J 6(1):51\u20136","journal-title":"Sultan Qaboos Univ Med J"},{"key":"5210_CR91","doi-asserted-by":"crossref","first-page":"1210393","DOI":"10.3389\/fphar.2023.1210393","volume":"14","author":"TJ Xia","year":"2023","unstructured":"Xia TJ et al (2023) Melatonin-related dysfunction in chronic restraint stress triggers sleep disorders in mice. Front Pharmacol 14:1210393","journal-title":"Front Pharmacol"},{"issue":"6","key":"5210_CR92","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/sleep\/33.6.833","volume":"33","author":"SP Fisher","year":"2010","unstructured":"Fisher SP, Sugden D (2010) Endogenous melatonin is not obligatory for the regulation of the rat sleep-wake cycle. Sleep 33(6):833\u201340","journal-title":"Sleep"},{"key":"5210_CR93","doi-asserted-by":"crossref","first-page":"1486548","DOI":"10.3389\/fneur.2025.1486548","volume":"16","author":"N Tang","year":"2025","unstructured":"Tang N et al (2025) Interference between immune cells and insomnia: a bibliometric analysis from 2000 to 2023. Front Neurol 16:1486548","journal-title":"Front Neurol"},{"key":"5210_CR94","doi-asserted-by":"crossref","unstructured":"Barone P (2019)\u00a0The \u2018Yin\u2019 and the \u2018Yang\u2019 of the kynurenine pathway: excitotoxicity and neuroprotection imbalance in stress-induced disorders. Behav Pharmacol\u00a030(2 and 3-Spec Issue):163-186","DOI":"10.1097\/FBP.0000000000000477"},{"issue":"3","key":"5210_CR95","doi-asserted-by":"crossref","first-page":"C343","DOI":"10.1152\/ajpcell.00095.2018","volume":"315","author":"W Abdullahi","year":"2018","unstructured":"Abdullahi W, Tripathi D, Ronaldson PT (2018) Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. American Journal of Physiology-Cell Physiology 315(3):C343\u2013C356","journal-title":"Am J Physiol Cell Physiol"},{"key":"5210_CR96","doi-asserted-by":"crossref","unstructured":"Bo L, Guojun T, Li G (2018) An expanded neuroimmunomodulation axis: sCD83-indoleamine 2,3-dioxygenase\u2014kynurenine pathway and updates of kynurenine pathway in neurologic diseases. Front Immunol 9:1363","DOI":"10.3389\/fimmu.2018.01363"},{"key":"5210_CR97","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4137\/EHI.S38343","volume":"10","author":"C Jaeger","year":"2016","unstructured":"Jaeger C, Tischkau SA (2016) Role of aryl hydrocarbon receptor in circadian clock disruption and metabolic dysfunction. Environ Health Insights 10:133\u201341","journal-title":"Environ Health Insights"},{"key":"5210_CR98","doi-asserted-by":"crossref","unstructured":"Bratek-Gerej E et al (2021) The mechanism of the neuroprotective effect of kynurenic acid in the experimental model of neonatal hypoxia-ischemia: the link to oxidative stress. Antioxidants (Basel) 10(11):1775","DOI":"10.3390\/antiox10111775"},{"key":"5210_CR99","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3389\/fimmu.2017.01957","volume":"8","author":"E Wirthgen","year":"2017","unstructured":"Wirthgen E et al (2017) Kynurenic acid: the Janus-faced role of an immunomodulatory tryptophan metabolite and its link to pathological conditions. Front Immunol 8:1957","journal-title":"Front Immunol"},{"issue":"6","key":"5210_CR100","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/jnc.14907","volume":"152","author":"TW Stone","year":"2020","unstructured":"Stone TW (2020) Does kynurenic acid act on nicotinic receptors? An assessment of the evidence. J Neurochem 152(6):627\u2013649","journal-title":"J Neurochem"},{"issue":"31","key":"5210_CR101","doi-asserted-by":"crossref","first-page":"22021","DOI":"10.1074\/jbc.M603503200","volume":"281","author":"J Wang","year":"2006","unstructured":"Wang J et al (2006) Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 281(31):22021\u201322028","journal-title":"J Biol Chem"},{"key":"5210_CR102","doi-asserted-by":"crossref","first-page":"117864692097090","DOI":"10.1177\/1178646920970902","volume":"13","author":"A Bhat","year":"2020","unstructured":"Bhat A et al (2020) Effects of sleep deprivation on the tryptophan metabolism. International journal of tryptophan research\u202f: IJTR 13:1178646920970902\u20131178646920970902","journal-title":"Int J Tryptophan Res : IJTR"},{"key":"5210_CR103","doi-asserted-by":"crossref","unstructured":"Tanaka M, Szabo A, Vecsei L (2024) Redefining roles: a paradigm shift in tryptophan-kynurenine metabolism for innovative clinical applications. Int J Mol Sci 25(23):12767","DOI":"10.3390\/ijms252312767"},{"key":"5210_CR104","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4137\/IJTR.S14084","volume":"7","author":"M Yamashita","year":"2014","unstructured":"Yamashita M, Yamamoto T (2014) Tryptophan and kynurenic acid may produce an amplified effect in central fatigue induced by chronic sleep disorder. Int J Tryptophan Res 7:9\u201314","journal-title":"Int J Tryptophan Res"},{"key":"5210_CR105","doi-asserted-by":"crossref","first-page":"100204","DOI":"10.1016\/j.ynstr.2019.100204","volume":"12","author":"AM Baratta","year":"2020","unstructured":"Baratta AM et al (2020) Acute sleep deprivation during pregnancy in rats: rapid elevation of placental and fetal inflammation and kynurenic acid. Neurobiol Stress 12:100204","journal-title":"Neurobiol Stress"},{"issue":"1","key":"5210_CR106","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1038\/s41598-018-25288-w","volume":"8","author":"AM Baratta","year":"2018","unstructured":"Baratta AM et al (2018) Sex differences in hippocampal memory and kynurenic acid formation following acute sleep deprivation in rats. Sci Rep 8(1):6963","journal-title":"Sci Rep"},{"key":"5210_CR107","doi-asserted-by":"crossref","unstructured":"Baratta AM et al (2018) A high-performance liquid chromatography measurement of kynurenine and kynurenic acid: relating biochemistry to cognition and sleep in rats. J Vis Exp (138):58129","DOI":"10.3791\/58129"},{"key":"5210_CR108","doi-asserted-by":"crossref","unstructured":"Rentschler KM et al (2021) Prenatal kynurenine elevation elicits sex-dependent changes in sleep and arousal during adulthood: implications for psychotic disorders. Schizophr Bull 47(5):1320\u20131330","DOI":"10.1093\/schbul\/sbab029"},{"issue":"3","key":"5210_CR109","doi-asserted-by":"crossref","first-page":"e14038","DOI":"10.1111\/jsr.14038","volume":"33","author":"KM Rentschler","year":"2024","unstructured":"Rentschler KM et al (2024) Reducing brain kynurenic acid synthesis precludes kynurenine-induced sleep disturbances. J Sleep Res 33(3):e14038","journal-title":"J Sleep Res"},{"issue":"1","key":"5210_CR110","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41398-023-02399-1","volume":"13","author":"S Milosavljevic","year":"2023","unstructured":"Milosavljevic S et al (2023) Kynurenine aminotransferase II inhibition promotes sleep and rescues impairments induced by neurodevelopmental insult. Transl Psychiatry 13(1):106","journal-title":"Transl Psychiatry"},{"key":"5210_CR111","doi-asserted-by":"crossref","unstructured":"Buchanan JL, Rauckhorst AJ, Taylor EB (2023) 3-hydroxykynurenine is a ROS-inducing cytotoxic tryptophan metabolite that disrupts the TCA cycle. bioRxiv: the preprint server for biology 548411","DOI":"10.1101\/2023.07.10.548411"},{"key":"5210_CR112","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuro.2012.11.007","volume":"34","author":"AL Col\u00edn-Gonz\u00e1lez","year":"2013","unstructured":"Col\u00edn-Gonz\u00e1lez AL, Maldonado PD, Santamar\u00eda A (2013) 3-Hydroxykynurenine: an intriguing molecule exerting dual actions in the Central Nervous System. NeuroToxicology 34:189\u2013204","journal-title":"NeuroToxicology"},{"key":"5210_CR113","doi-asserted-by":"crossref","unstructured":"Mithaiwala MN et al (2021) Neuroinflammation and the kynurenine pathway in CNS disease: molecular mechanisms and therapeutic implications. Cells 10(6):1548","DOI":"10.3390\/cells10061548"},{"key":"5210_CR114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.09.034","volume":"1589","author":"AL Col\u00edn-Gonz\u00e1lez","year":"2014","unstructured":"Col\u00edn-Gonz\u00e1lez AL et al (2014) The Janus faces of 3-hydroxykynurenine: dual redox modulatory activity and lack of neurotoxicity in the rat striatum. Brain Res 1589:1\u201314","journal-title":"Brain Res"},{"key":"5210_CR115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fmolb.2019.00003","volume":"6","author":"RS Phillips","year":"2019","unstructured":"Phillips RS et al (2019) Modulation of enzyme activity in the kynurenine pathway by kynurenine monooxygenase inhibition. Front Mol Biosci 6:3","journal-title":"Front Mol Biosci"},{"issue":"3","key":"5210_CR116","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ajpath.2011.05.048","volume":"179","author":"D Krause","year":"2011","unstructured":"Krause D et al (2011) The tryptophan metabolite 3-hydroxyanthranilic acid plays anti-inflammatory and neuroprotective roles during inflammation: role of hemeoxygenase-1. Am J Pathol 179(3):1360\u201372","journal-title":"Am J Pathol"},{"key":"5210_CR117","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4137\/IJTR.S2318","volume":"2","author":"N Braidy","year":"2009","unstructured":"Braidy N et al (2009) Effects of kynurenine pathway metabolites on intracellular NAD synthesis and cell death in human primary astrocytes and neurons. Int J Tryptophan Res 2:61\u20139","journal-title":"Int J Tryptophan Res"},{"issue":"10","key":"5210_CR118","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1177\/1545968320953671","volume":"34","author":"P Carrillo-Mora","year":"2020","unstructured":"Carrillo-Mora P et al (2020) Serum kynurenines correlate with depressive symptoms and disability in poststroke patients: a cross-sectional study. Neurorehabil Neural Repair 34(10):936\u2013944","journal-title":"Neurorehabil Neural Repair"},{"key":"5210_CR119","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.abb.2013.10.020","volume":"544","author":"RS Phillips","year":"2014","unstructured":"Phillips RS (2014) Structure and mechanism of kynureninase. Arch Biochem Biophys 544:69\u201374","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"5210_CR120","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.1503\/jpn.190139","volume":"46","author":"T Pawlowski","year":"2021","unstructured":"Pawlowski T et al (2021) The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-\u03b12a and oral ribavirin. J Psychiatry Neurosci 46(1):E166-e175","journal-title":"J Psychiatry Neurosci"},{"key":"5210_CR121","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4137\/IJTR.S2469","volume":"2","author":"RS Grant","year":"2009","unstructured":"Grant RS, Coggan SE, Smythe GA (2009) The physiological action of picolinic acid in the human brain. Int J Tryptophan Res 2:71\u20139","journal-title":"Int J Tryptophan Res"},{"issue":"1\u20132","key":"5210_CR122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(94)90504-5","volume":"668","author":"BE Kalisch","year":"1994","unstructured":"Kalisch BE et al (1994) Picolinic acid protects against quinolinic acid-induced depletion of NADPH diaphorase containing neurons in the rat striatum. Brain Res 668(1\u20132):1\u20138","journal-title":"Brain Res"},{"key":"5210_CR123","doi-asserted-by":"crossref","unstructured":"Hestad K et al (2022) The role of tryptophan dysmetabolism and quinolinic acid in depressive and neurodegenerative diseases. Biomolecules 12(7):998","DOI":"10.3390\/biom12070998"},{"issue":"5","key":"5210_CR124","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1471-4159.2009.05868.x","volume":"108","author":"SE Coggan","year":"2009","unstructured":"Coggan SE et al (2009) Age and circadian influences on picolinic acid concentrations in human cerebrospinal fluid. J Neurochem 108(5):1220\u20135","journal-title":"J Neurochem"},{"key":"5210_CR125","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-De La Cruz V, Carrillo-Mora P, Santamar\u00eda A (2012)\u00a0Quinolinic acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms. Int J Tryptophan Res\u00a05:1-8","DOI":"10.4137\/IJTR.S8158"},{"issue":"8","key":"5210_CR126","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","volume":"279","author":"GJ Guillemin","year":"2012","unstructured":"Guillemin GJ (2012) Quinolinic acid, the inescapable neurotoxin. Febs j 279(8):1356\u201365","journal-title":"Febs J"},{"issue":"3","key":"5210_CR127","doi-asserted-by":"crossref","first-page":"127","DOI":"10.13078\/jsm.240015","volume":"21","author":"K Abbas","year":"2024","unstructured":"Abbas K et al (2024) Chronotherapeutic and epigenetic regulation of circadian rhythms: nicotinamide adenine dinucleotide-sirtuin axis. Journal of Sleep Medicine 21(3):127\u2013133","journal-title":"J Sleep Med"},{"issue":"2","key":"5210_CR128","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbr.2011.08.007","volume":"225","author":"NG Hern\u00e1ndez-Chan","year":"2011","unstructured":"Hern\u00e1ndez-Chan NG et al (2011) Quinolinic acid lesions of the pedunculopontine nucleus impair sleep architecture, but not locomotion, exploration, emotionality or working memory in the rat. Behav Brain Res 225(2):482\u201390","journal-title":"Behav Brain Res"},{"key":"5210_CR129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0028-3908(80)90133-1","volume":"19","author":"WJ Wojcik","year":"1980","unstructured":"Wojcik WJ, Fornal CA, Radulova\u010dki M (1980) Effect of tryptophan on sleep in the rat. Neuropharmacology 19:163\u2013167","journal-title":"Neuropharmacology"},{"issue":"3","key":"5210_CR130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00702-012-0901-0","volume":"120","author":"A Bridoux","year":"2013","unstructured":"Bridoux A et al (2013) The acute inhibition of rapid eye movement sleep by citalopram may impair spatial learning and passive avoidance in mice. J Neural Transm (Vienna) 120(3):383\u20139","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"5210_CR131","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13195-019-0547-3","volume":"12","author":"O Grau-Rivera","year":"2020","unstructured":"Grau-Rivera O et al (2020) Association between insomnia and cognitive performance, gray matter volume, and white matter microstructure in cognitively unimpaired adults. Alzheimers Res Ther 12(1):4","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"5210_CR132","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.smrv.2012.06.007","volume":"17","author":"ML Jackson","year":"2013","unstructured":"Jackson ML et al (2013) Deconstructing and reconstructing cognitive performance in sleep deprivation. Sleep Med Rev 17(3):215\u201325","journal-title":"Sleep Med Rev"},{"key":"5210_CR133","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.comppsych.2019.02.006","volume":"91","author":"JF Laskemoen","year":"2019","unstructured":"Laskemoen JF et al (2019) Sleep disturbances in schizophrenia spectrum and bipolar disorders \u2013 a transdiagnostic perspective. Comprehensive Psychiatry 91:6\u201312","journal-title":"Compr Psychiatry"},{"key":"5210_CR134","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pnpbp.2019.01.016","volume":"92","author":"I Robertson","year":"2019","unstructured":"Robertson I, Cheung A, Fan X (2019) Insomnia in patients with schizophrenia: current understanding and treatment options. Progress in Neuro-Psychopharmacology and Biological Psychiatry 92:235\u2013242","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"6","key":"5210_CR135","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.neubiorev.2009.03.006","volume":"33","author":"D Mendelsohn","year":"2009","unstructured":"Mendelsohn D, Riedel WJ, Sambeth A (2009) Effects of acute tryptophan depletion on memory, attention and executive functions: a systematic review. Neurosci Biobehav Rev 33(6):926\u201352","journal-title":"Neurosci Biobehav Rev"},{"key":"5210_CR136","doi-asserted-by":"crossref","first-page":"8604718","DOI":"10.1155\/2018\/8604718","volume":"2018","author":"LA Ramos-Chavez","year":"2018","unstructured":"Ramos-Chavez LA et al (2018) Low serum tryptophan levels as an indicator of global cognitive performance in nondemented women over 50 years of age. Oxid Med Cell Longev 2018:8604718","journal-title":"Oxid Med Cell Longev"},{"issue":"10","key":"5210_CR137","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1038\/npp.2016.66","volume":"41","author":"J Chiappelli","year":"2016","unstructured":"Chiappelli J et al (2016) Tryptophan metabolism and white matter integrity in schizophrenia. Neuropsychopharmacology 41(10):2587\u201395","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"5210_CR138","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1503\/jpn.140126","volume":"40","author":"L Schwieler","year":"2015","unstructured":"Schwieler L et al (2015) Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia\u2013significance for activation of the kynurenine pathway. J Psychiatry Neurosci 40(2):126\u201333","journal-title":"J Psychiatry Neurosci"},{"key":"5210_CR139","doi-asserted-by":"crossref","unstructured":"Bhat AR et al (2020)\u00a0Effects of sleep deprivation on the tryptophan metabolism. Int J Tryptophan Res: IJTR\u00a013","DOI":"10.1177\/1178646920970902"},{"key":"5210_CR140","doi-asserted-by":"crossref","first-page":"115423","DOI":"10.1016\/j.psychres.2023.115423","volume":"328","author":"C Kuuskm\u00e4e","year":"2023","unstructured":"Kuuskm\u00e4e C et al (2023) Kynurenine pathway dynamics in patients with schizophrenia spectrum disorders across the disease trajectory. Psychiatry Res 328:115423","journal-title":"Psychiatry Research"},{"key":"5210_CR141","doi-asserted-by":"crossref","unstructured":"Markovi\u0107 M et al (2023)\u00a0Decreased plasma levels of kynurenine and kynurenic acid in previously treated and first-episode antipsychotic-naive schizophrenia patients. Cells\u00a012(24)","DOI":"10.3390\/cells12242814"},{"key":"5210_CR142","first-page":"204","volume":"40","author":"HQ Wu","year":"2009","unstructured":"Wu HQ et al (2010) The astrocyte-derived \u03b17 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex. J Mol Neurosci 40(1-2):204\u2013210","journal-title":"J Mol Neurosci"},{"key":"5210_CR143","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2005.12.056","volume":"1073\u20131074","author":"CL Miller","year":"2006","unstructured":"Miller CL et al (2006) Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder. Brain Res 1073\u20131074:25\u201337","journal-title":"Brain Res"},{"key":"5210_CR144","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neubiorev.2021.01.018","volume":"123","author":"B Cao","year":"2021","unstructured":"Cao B et al (2021) Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: a systematic review and meta-analysis. Neurosci Biobehav Rev 123:203\u2013214","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"5210_CR145","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/schbul\/sbq086","volume":"38","author":"KR Linderholm","year":"2012","unstructured":"Linderholm KR et al (2012) Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia. Schizophr Bull 38(3):426\u201332","journal-title":"Schizophr Bull"},{"issue":"2\u20133","key":"5210_CR146","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.schres.2005.07.013","volume":"80","author":"LK Nilsson","year":"2005","unstructured":"Nilsson LK et al (2005) Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia. Schizophr Res 80(2\u20133):315\u201322","journal-title":"Schizophr Res"},{"issue":"4","key":"5210_CR147","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/schbul\/sbw221","volume":"43","author":"E Plitman","year":"2017","unstructured":"Plitman E et al (2017) Kynurenic acid in schizophrenia: a systematic review and meta-analysis. Schizophr Bull 43(4):764\u2013777","journal-title":"Schizophr Bull"},{"key":"5210_CR148","doi-asserted-by":"crossref","first-page":"10592","DOI":"10.1523\/JNEUROSCI.1107-14.2014","volume":"34","author":"R Kozak","year":"2014","unstructured":"Kozak R et al (2014) Reduction of brain kynurenic acid improves cognitive function. The Journal of Neuroscience 34:10592\u201310602","journal-title":"J Neurosci"},{"issue":"2","key":"5210_CR149","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/schbul\/sbq002","volume":"36","author":"I Wonodi","year":"2010","unstructured":"Wonodi I, Schwarcz R (2010) Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in schizophrenia. Schizophrenia Bulletin 36(2):211\u2013218","journal-title":"Schizophrenia Bulletin"},{"issue":"1","key":"5210_CR150","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41398-021-01311-z","volume":"11","author":"J Huang","year":"2021","unstructured":"Huang J et al (2021) Effects of neuroactive metabolites of the tryptophan pathway on working memory and cortical thickness in schizophrenia. Transl Psychiatry 11(1):198","journal-title":"Transl Psychiatry"},{"key":"5210_CR151","doi-asserted-by":"crossref","unstructured":"Porter GA, O'Connor JC (2021)\u00a0Chronic unpredictable stress alters brain tryptophan metabolism and impairs working memory in mice without causing depression-like behaviour. Neurol Neurobiol (Tallinn)\u00a04(3)","DOI":"10.31487\/j.NNB.2021.03.03"},{"key":"5210_CR152","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbr.2016.06.018","volume":"312","author":"LK Too","year":"2016","unstructured":"Too LK et al (2016) Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function. Behav Brain Res 312:102\u201317","journal-title":"Behav Brain Res"},{"issue":"10","key":"5210_CR153","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/j.1460-9568.2012.08064.x","volume":"35","author":"A Pocivavsek","year":"2012","unstructured":"Pocivavsek A et al (2012) Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood. Eur J Neurosci 35(10):1605\u201312","journal-title":"Eur J Neurosci"},{"issue":"2","key":"5210_CR154","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hipo.23040","volume":"29","author":"A Pocivavsek","year":"2019","unstructured":"Pocivavsek A, Elmer GI, Schwarcz R (2019) Inhibition of kynurenine aminotransferase II attenuates hippocampus-dependent memory deficit in adult rats treated prenatally with kynurenine. Hippocampus 29(2):73\u201377","journal-title":"Hippocampus"},{"key":"5210_CR155","doi-asserted-by":"crossref","first-page":"107282","DOI":"10.1016\/j.nlm.2020.107282","volume":"174","author":"SA Buck","year":"2020","unstructured":"Buck SA, Baratta AM, Pocivavsek A (2020) Exposure to elevated embryonic kynurenine in rats: sex-dependent learning and memory impairments in adult offspring. Neurobiol Learn Mem 174:107282","journal-title":"Neurobiol Learn Mem"},{"issue":"6","key":"5210_CR156","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1017\/S1461145710001689","volume":"14","author":"R Condray","year":"2011","unstructured":"Condray R et al (2011) 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia. Int J Neuropsychopharmacol 14(6):756\u201367","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"5210_CR157","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00406-012-0384-x","volume":"263","author":"MJ Schwarz","year":"2013","unstructured":"Schwarz MJ et al (2013) Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer\u2019s disease patients from controls. Eur Arch Psychiatry Clin Neurosci 263(4):345\u201352","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"5210_CR158","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuro.2015.08.003","volume":"50","author":"J Reyes-Ocampo","year":"2015","unstructured":"Reyes-Ocampo J et al (2015) Mitochondrial dysfunction related to cell damage induced by 3-hydroxykynurenine and 3-hydroxyanthranilic acid: non-dependent-effect of early reactive oxygen species production. Neurotoxicology 50:81\u201391","journal-title":"Neurotoxicology"},{"issue":"24","key":"5210_CR159","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.1021\/bi992997s","volume":"39","author":"LE Goldstein","year":"2000","unstructured":"Goldstein LE et al (2000) 3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction. Biochemistry 39(24):7266\u201375","journal-title":"Biochemistry"},{"key":"5210_CR160","doi-asserted-by":"crossref","unstructured":"Pierozan P et al (2014) Biochemical, histopathological and behavioral alterations caused by intrastriatal administration of quinolic acid to young rats. FEBS J 281(8):2061\u20132073","DOI":"10.1111\/febs.12762"},{"key":"5210_CR161","doi-asserted-by":"crossref","unstructured":"Heyes MP et al (1991) Quinolinic acid in cerebrospinal fluid and serum in HIV\u20101 Infection: relationship to clinical and neurological status. Ann Neurol 29(2):202\u2013209","DOI":"10.1002\/ana.410290215"},{"key":"5210_CR162","doi-asserted-by":"crossref","unstructured":"Anderson EW et al (2021) Quinolinic acid, a kynurenine\/tryptophan pathway metabolite, associates with impaired cognitive test performance in systemic lupus erythematosus. Lupus Sci Med 8(1):e000559","DOI":"10.1136\/lupus-2021-000559"},{"issue":"4","key":"5210_CR163","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/sleep\/31.4.473","volume":"31","author":"DJ Buysse","year":"2008","unstructured":"Buysse DJ et al (2008) Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep 31(4):473\u201380","journal-title":"Sleep"},{"key":"5210_CR164","doi-asserted-by":"crossref","unstructured":"Thase ME, Murck H, Post A (2010) Clinical relevance of disturbances of sleep and vigilance in major depressive disorder: a review. Prim Care Companion J Clin Psychiatry 12(6):PCC.08m00676","DOI":"10.4088\/PCC.08m00676gry"},{"key":"5210_CR165","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/7854_2015_367","volume":"25","author":"P Meerlo","year":"2015","unstructured":"Meerlo P, Havekes R, Steiger A (2015) Chronically restricted or disrupted sleep as a causal factor in the development of depression. Curr Top Behav Neurosci 25:459\u201381","journal-title":"Curr Top Behav Neurosci"},{"key":"5210_CR166","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.smrv.2019.01.001","volume":"44","author":"AS Tubbs","year":"2019","unstructured":"Tubbs AS, Perlis ML, Grandner MA (2019) Surviving the long night: the potential of sleep health for suicide prevention. Sleep Med Rev 44:83\u201384","journal-title":"Sleep Med Rev"},{"issue":"1","key":"5210_CR167","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-0327(89)90051-7","volume":"16","author":"PJ Cowen","year":"1989","unstructured":"Cowen PJ, Parry-Billings M, Newsholme EA (1989) Decreased plasma tryptophan levels in major depression. J Affect Disord 16(1):27\u201331","journal-title":"J Affect Disord"},{"issue":"6","key":"5210_CR168","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00005072-200606000-00004","volume":"65","author":"L Zhang","year":"2006","unstructured":"Zhang L et al (2006) Rats subjected to extended L-tryptophan restriction during early postnatal stage exhibit anxious-depressive features and structural changes. J Neuropathol Exp Neurol 65(6):562\u201370","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"5210_CR169","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/0269881105051538","volume":"19","author":"L Booij","year":"2005","unstructured":"Booij L et al (2005) The effects of high-dose and low-dose tryptophan depletion on mood and cognitive functions of remitted depressed patients. J Psychopharmacol 19(3):267\u201375","journal-title":"J Psychopharmacol"},{"key":"5210_CR170","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.neubiorev.2021.05.018","volume":"127","author":"SJ Brown","year":"2021","unstructured":"Brown SJ, Huang XF, Newell KA (2021) The kynurenine pathway in major depression: what we know and where to next. Neurosci Biobehav Rev 127:917\u2013927","journal-title":"Neurosci Biobehav Rev"},{"key":"5210_CR171","doi-asserted-by":"crossref","first-page":"110226","DOI":"10.1016\/j.pnpbp.2020.110226","volume":"107","author":"G Arteaga-Henriquez","year":"2021","unstructured":"Arteaga-Henriquez G et al (2021) Activation and deactivation steps in the tryptophan breakdown pathway in major depressive disorder: a link to the monocyte inflammatory state of patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 107:110226","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"2","key":"5210_CR172","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/pcn.12944","volume":"74","author":"R Colle","year":"2020","unstructured":"Colle R et al (2020) Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: a case\u2013control study. Psychiatry and Clinical Neurosciences 74(2):112\u2013117","journal-title":"Psychiatry Clin Neurosci"},{"issue":"14","key":"5210_CR173","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1523\/JNEUROSCI.4006-07.2008","volume":"28","author":"D Popa","year":"2008","unstructured":"Popa D et al (2008) Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior. J Neurosci 28(14):3546\u201354","journal-title":"J Neurosci"},{"issue":"Suppl 11","key":"5210_CR174","first-page":"46","volume":"61","author":"ME Thase","year":"2000","unstructured":"Thase ME (2000) Treatment issues related to sleep and depression. J Clin Psychiatry 61(Suppl 11):46\u201350","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"5210_CR175","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/smrv.1999.0075","volume":"4","author":"L Lustberg","year":"2000","unstructured":"Lustberg L, Reynolds CF (2000) Depression and insomnia: questions of cause and effect. Sleep Med Rev 4(3):253\u2013262","journal-title":"Sleep Med Rev"},{"issue":"1","key":"5210_CR176","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.smrv.2009.04.002","volume":"14","author":"D Riemann","year":"2010","unstructured":"Riemann D et al (2010) The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev 14(1):19\u201331","journal-title":"Sleep Med Rev"},{"issue":"4","key":"5210_CR177","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/15402002.2013.801346","volume":"12","author":"B Farina","year":"2014","unstructured":"Farina B et al (2014) Heart rate and heart rate variability modification in chronic insomnia patients. Behav Sleep Med 12(4):290\u2013306","journal-title":"Behav Sleep Med"},{"issue":"3","key":"5210_CR178","first-page":"236","volume":"9","author":"JO Onaolapo","year":"2016","unstructured":"Onaolapo JO et al (2016) Caffeine and sleep-deprivation mediated changes in open-field behaviours, stress response and antioxidant status in mice. Sleep science (Sao Paulo, Brazil) 9(3):236\u2013243","journal-title":"Sleep science (Sao Paulo, Brazil)"},{"key":"5210_CR179","doi-asserted-by":"crossref","unstructured":"Vuotto SC, Lam ASM, Cheung YT (2022)\u00a0Chapter 8 - Tryptophan and metabolites (serotonin and kynurenines) in posttraumatic stress disorder, in Biophotonics, Tryptophan and Disease.\u00a0L.A. Sordillo and P.P. Sordillo, Eds. Academic Press. pp. 93-105","DOI":"10.1016\/B978-0-12-822790-9.00007-3"},{"key":"5210_CR180","doi-asserted-by":"crossref","first-page":"636144","DOI":"10.3389\/fnhum.2021.636144","volume":"15","author":"JD Coplan","year":"2021","unstructured":"Coplan JD et al (2021) Early life stress and the fate of kynurenine pathway metabolites. Front Hum Neurosci 15:636144","journal-title":"Front Hum Neurosci"},{"key":"5210_CR181","doi-asserted-by":"crossref","first-page":"865576","DOI":"10.3389\/fphar.2022.865576","volume":"13","author":"JH Jang","year":"2022","unstructured":"Jang JH et al (2022) The kynurenine pathway and mediating role of stress in addictive disorders: a focus on alcohol use disorder and internet gaming disorder. Front Pharmacol 13:865576","journal-title":"Front Pharmacol"},{"key":"5210_CR182","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-981-32-9705-0_10","volume":"1191","author":"A Evrensel","year":"2020","unstructured":"Evrensel A, \u00dcnsalver B, Ceylan ME (2020) Immune-kynurenine pathways and the gut microbiota-brain axis in anxiety disorders. Adv Exp Med Biol 1191:155\u2013167","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"5210_CR183","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000455228","volume":"38","author":"FM Notarangelo","year":"2016","unstructured":"Notarangelo FM, Schwarcz R (2016) Restraint stress during pregnancy rapidly raises kynurenic acid levels in mouse placenta and fetal brain. Dev Neurosci 38(6):458\u2013468","journal-title":"Dev Neurosci"},{"issue":"8","key":"5210_CR184","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00702-022-02525-1","volume":"129","author":"M Kucukkarapinar","year":"2022","unstructured":"Kucukkarapinar M et al (2022) Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress. J Neural Transm (Vienna) 129(8):1077\u20131089","journal-title":"J Neural Transm (Vienna)"},{"key":"5210_CR185","doi-asserted-by":"crossref","unstructured":"Funakoshi H, Kanai M, Nakamura T (2011) Modulation of tryptophan metabolism, promotion of neurogenesis and alteration of anxiety-related behavior in tryptophan 2,3-dioxygenase-deficient mice. Int J Tryptophan Res 4:7\u201318","DOI":"10.4137\/IJTR.S5783"},{"key":"5210_CR186","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-6606-2-8","volume":"2","author":"M Kanai","year":"2009","unstructured":"Kanai M et al (2009) Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice. Mol Brain 2:8","journal-title":"Mol Brain"},{"issue":"1","key":"5210_CR187","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s12035-018-1096-7","volume":"56","author":"D Martin-Hernandez","year":"2019","unstructured":"Martin-Hernandez D et al (2019) Chronic mild stress alters kynurenine pathways changing the glutamate neurotransmission in frontal cortex of rats. Mol Neurobiol 56(1):490\u2013501","journal-title":"Mol Neurobiol"},{"key":"5210_CR188","doi-asserted-by":"crossref","unstructured":"Hasegawa M et al (2025) Chronic stress induces behavioural changes through increased kynurenic acid by downregulation of kynurenine-3-monooxygenase with microglial decline. Br J Pharmacol 182(7):1466\u20131486","DOI":"10.1111\/bph.17407"},{"issue":"1","key":"5210_CR189","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pbb.2010.12.008","volume":"98","author":"A Laugeray","year":"2011","unstructured":"Laugeray A et al (2011) Evidence for a key role of the peripheral kynurenine pathway in the modulation of anxiety- and depression-like behaviours in mice: focus on individual differences. Pharmacol Biochem Behav 98(1):161\u2013168","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"5210_CR190","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3109\/10253890.2010.541539","volume":"14","author":"H Miura","year":"2011","unstructured":"Miura H et al (2011) Long-lasting effects of inescapable-predator stress on brain tryptophan metabolism and the behavior of juvenile mice. Stress 14(3):262\u201372","journal-title":"Stress"},{"issue":"5","key":"5210_CR191","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.3390\/ijms24054389","volume":"24","author":"AS Correia","year":"2023","unstructured":"Correia AS et al (2023) The effect of the stress induced by hydrogen peroxide and corticosterone on tryptophan metabolism, using human neuroblastoma cell line (SH-SY5Y). International Journal of Molecular Sciences 24(5):4389","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5210_CR192","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12974-022-02508-9","volume":"19","author":"M Hersey","year":"2022","unstructured":"Hersey M et al (2022) A tale of two transmitters: serotonin and histamine as in vivo biomarkers of chronic stress in mice. Journal of Neuroinflammation 19(1):167","journal-title":"J Neuroinflammation"},{"issue":"4","key":"5210_CR193","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biopsych.2024.01.024","volume":"96","author":"R Ramkumar","year":"2024","unstructured":"Ramkumar R et al (2024) Long-term impact of early-life stress on serotonin connectivity. Biological Psychiatry 96(4):287\u2013299","journal-title":"Biological Psychiatry"},{"issue":"6","key":"5210_CR194","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1159\/000526647","volume":"44","author":"CA Moura","year":"2022","unstructured":"Moura CA et al (2022) Maternal stress during pregnancy in mice induces sex-dependent behavioral alterations in offspring along with impaired serotonin and kynurenine pathways of tryptophan metabolism. Dev Neurosci 44(6):603\u2013614","journal-title":"Dev Neurosci"},{"key":"5210_CR195","doi-asserted-by":"crossref","first-page":"111289","DOI":"10.1016\/j.foodres.2022.111289","volume":"157","author":"D Wang","year":"2022","unstructured":"Wang D et al (2022) Tryptophan-rich diet ameliorates chronic unpredictable mild stress induced depression- and anxiety-like behavior in mice: the potential involvement of gut-brain axis. Food Research International 157:111289","journal-title":"Food Res Int"},{"issue":"6","key":"5210_CR196","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/j.pain.0000000000000160","volume":"156","author":"RD Treede","year":"2015","unstructured":"Treede RD et al (2015) A classification of chronic pain for ICD-11. Pain 156(6):1003\u20131007","journal-title":"Pain"},{"key":"5210_CR197","doi-asserted-by":"crossref","unstructured":"Auyeung A et al (2023) Kynurenine pathway metabolites as potential biomarkers in chronic pain. Pharmaceuticals (Basel) 16(5):681","DOI":"10.3390\/ph16050681"},{"issue":"1","key":"5210_CR198","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/204946370800200102","volume":"2","author":"NK Tang","year":"2008","unstructured":"Tang NK (2008) Insomnia co-occurring with chronic pain: clinical features, interaction, assessments and possible interventions. Rev Pain 2(1):2\u20137","journal-title":"Rev Pain"},{"key":"5210_CR199","doi-asserted-by":"crossref","first-page":"1122381","DOI":"10.3389\/fnsyn.2023.1122381","volume":"15","author":"S Hao","year":"2023","unstructured":"Hao S et al (2023) Multiple modulatory roles of serotonin in chronic pain and injury-related anxiety. Front Synaptic Neurosci 15:1122381","journal-title":"Front Synaptic Neurosci"},{"issue":"2","key":"5210_CR200","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/joor.12892","volume":"47","author":"G Barjandi","year":"2020","unstructured":"Barjandi G et al (2020) Plasma tryptophan and kynurenine in females with temporomandibular disorders and fibromyalgia\u2014an exploratory pilot study. Journal of Oral Rehabilitation 47(2):150\u2013157","journal-title":"J Oral Rehabil"},{"issue":"295","key":"5210_CR201","first-page":"5","volume":"50","author":"C Chojnacki","year":"2022","unstructured":"Chojnacki C et al (2022) Altered tryptophan metabolism in patients with recurrent functional abdominal pain. Pol Merkur Lekarski 50(295):5\u20138","journal-title":"Pol Merkur Lekarski"},{"key":"5210_CR202","doi-asserted-by":"crossref","unstructured":"Curto M et al (2016) Altered kynurenine pathway metabolites in serum of chronic migraine patients. J Headache Pain 17(1):47","DOI":"10.1186\/s10194-016-0638-5"},{"key":"5210_CR203","doi-asserted-by":"crossref","unstructured":"Curto M et al (2016) Altered serum levels of kynurenine metabolites in patients affected by cluster headache. J Headache Pain 17(1):27","DOI":"10.1186\/s10194-016-0620-2"},{"issue":"9\u201310","key":"5210_CR204","first-page":"313","volume":"55","author":"G K\u00e9kesi","year":"2002","unstructured":"K\u00e9kesi G, Horv\u00e1th G (2002) Analgesic effect of kynurenic acid. Ideggyogy Sz 55(9\u201310):313\u201322","journal-title":"Ideggyogy Sz"},{"key":"5210_CR205","doi-asserted-by":"crossref","unstructured":"Cs\u00e1ti A et al (2015) Kynurenic acid modulates experimentally induced inflammation in the trigeminal ganglion. J Headache Pain 16(1):99","DOI":"10.1186\/s10194-015-0581-x"},{"issue":"13","key":"5210_CR206","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1177\/0333102416678000","volume":"37","author":"R Greco","year":"2016","unstructured":"Greco R et al (2016) Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: targets and anti-migraine mechanisms. Cephalalgia 37(13):1272\u20131284","journal-title":"Cephalalgia"},{"key":"5210_CR207","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuropharm.2016.04.038","volume":"108","author":"F Resta","year":"2016","unstructured":"Resta F et al (2016) Kynurenic acid and zaprinast induce analgesia by modulating HCN channels through GPR35 activation. Neuropharmacology 108:136\u2013143","journal-title":"Neuropharmacology"},{"key":"5210_CR208","doi-asserted-by":"crossref","unstructured":"Hazrati E et al (2024)\u00a0Understanding the kynurenine pathway: a narrative review on its impact across chronic pain conditions. Molecular Pain\u00a020","DOI":"10.1177\/17448069241275097"},{"issue":"1","key":"5210_CR209","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.36076\/ppj.2020\/23\/E41","volume":"23","author":"J Gunn","year":"2020","unstructured":"Gunn J et al (2020) An analysis of biomarkers in patients with chronic pain. Pain Physician 23(1):E41\u2013E49","journal-title":"Pain Physician"},{"key":"5210_CR210","doi-asserted-by":"crossref","first-page":"105287","DOI":"10.1016\/j.psyneuen.2021.105287","volume":"131","author":"N Groven","year":"2021","unstructured":"Groven N et al (2021) Kynurenine metabolites and ratios differ between chronic fatigue syndrome, fibromyalgia, and healthy controls. Psychoneuroendocrinology 131:105287","journal-title":"Psychoneuroendocrinology"},{"issue":"19","key":"5210_CR211","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1007\/s00213-017-4686-6","volume":"234","author":"SL Martin","year":"2017","unstructured":"Martin SL et al (2017) 5-HT modulation of pain perception in humans. Psychopharmacology (Berl) 234(19):2929\u20132939","journal-title":"Psychopharmacology (Berl)"},{"key":"5210_CR212","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/jrms.JRMS_859_17","volume":"23","author":"MSM Al-Nimer","year":"2018","unstructured":"Al-Nimer MSM, Mohammad TAM, Alsakeni RA (2018) Serum levels of serotonin as a biomarker of newly diagnosed fibromyalgia in women: its relation to the platelet indices. J Res Med Sci 23:71","journal-title":"J Res Med Sci"},{"issue":"1","key":"5210_CR213","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s10194-016-0711-0","volume":"18","author":"CF Gasparini","year":"2017","unstructured":"Gasparini CF, Smith RA, Griffiths LR (2017) Genetic and biochemical changes of the serotonergic system in migraine pathobiology. J Headache Pain 18(1):20","journal-title":"J Headache Pain"},{"key":"5210_CR214","first-page":"4901242","volume":"2018","author":"A Farhanchi","year":"2018","unstructured":"Farhanchi A et al (2018) Association of serum serotonin and pain in patients with chronic low back pain before and after spinal surgery. Pain Res Treat 2018:4901242","journal-title":"Pain Res Treat"},{"key":"5210_CR215","doi-asserted-by":"crossref","unstructured":"Sarzi Puttini P, Caruso I (1992)\u00a0Primary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: a 90-day open study. J Int Med Res\u00a020(2):182-9","DOI":"10.1177\/030006059202000210"},{"issue":"3","key":"5210_CR216","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/030006059001800304","volume":"18","author":"I Caruso","year":"1990","unstructured":"Caruso I et al (1990) Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 18(3):201\u20139","journal-title":"J Int Med Res"},{"key":"5210_CR217","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s13075-015-0884-y","volume":"17","author":"TH Yang","year":"2015","unstructured":"Yang TH et al (2015) Supplement of 5-hydroxytryptophan before induction suppresses inflammation and collagen-induced arthritis. Arthritis Res Ther 17:364","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"5210_CR218","first-page":"274","volume":"150","author":"V Srinivasan","year":"2012","unstructured":"Srinivasan V et al (2012) Melatonin and its agonists in pain modulation and its clinical application. Arch Ital Biol 150(4):274\u201389","journal-title":"Arch Ital Biol"},{"issue":"2","key":"5210_CR219","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.j.pain.0000460311.71572.5f","volume":"156","author":"M Lopez-Canul","year":"2015","unstructured":"Lopez-Canul M et al (2015) Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways. Pain 156(2):305\u2013317","journal-title":"Pain"},{"key":"5210_CR220","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-981-13-1756-9_19","volume":"1099","author":"T Kaur","year":"2018","unstructured":"Kaur T, Shyu BC (2018) Melatonin: a new-generation therapy for reducing chronic pain and improving sleep disorder-related pain. Adv Exp Med Biol 1099:229\u2013251","journal-title":"Adv Exp Med Biol"},{"key":"5210_CR221","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Flores D et al (2023) Melatonin as a coadjuvant in the treatment of patients with fibromyalgia. Biomedicines 11(7):1964","DOI":"10.3390\/biomedicines11071964"},{"issue":"11","key":"5210_CR222","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00228-021-03170-5","volume":"77","author":"M Shokri","year":"2021","unstructured":"Shokri M et al (2021) Adjuvant use of melatonin for relieving symptoms of painful diabetic neuropathy: results of a randomized, double-blinded, controlled trial. European Journal of Clinical Pharmacology 77(11):1649\u20131663","journal-title":"Eur J Clin Pharmacol"},{"issue":"59","key":"5210_CR223","doi-asserted-by":"crossref","first-page":"100582","DOI":"10.18632\/oncotarget.21504","volume":"8","author":"C Zhu","year":"2017","unstructured":"Zhu C et al (2017) Exogenous melatonin in the treatment of pain: a systematic review and meta-analysis. Oncotarget 8(59):100582\u2013100592","journal-title":"Oncotarget"},{"key":"5210_CR224","doi-asserted-by":"crossref","unstructured":"Andersen LP (2016) The analgesic effects of exogenous melatonin in humans. Dan Med J 63(10):B5289","DOI":"10.1111\/aas.12747"},{"issue":"3","key":"5210_CR225","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1600-079X.2011.00895.x","volume":"51","author":"M Wilhelmsen","year":"2011","unstructured":"Wilhelmsen M et al (2011) Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies. J Pineal Res 51(3):270\u2013277","journal-title":"J Pineal Res"},{"key":"5210_CR226","doi-asserted-by":"crossref","unstructured":"Laste G et al (2012) Melatonin administration reduces inflammatory pain in rats. J Pain Res 5:359\u2013362","DOI":"10.2147\/JPR.S34019"},{"key":"5210_CR227","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/JPR.S228577","volume":"13","author":"S Xie","year":"2020","unstructured":"Xie S et al (2020) Role of melatonin in the regulation of pain. J Pain Res 13:331\u2013343","journal-title":"J Pain Res"},{"issue":"4","key":"5210_CR228","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/1545968304271405","volume":"18","author":"MC Ouellet","year":"2004","unstructured":"Ouellet MC, Savard J, Morin CM (2004) Insomnia following traumatic brain injury: a review. Neurorehabil Neural Repair 18(4):187\u201398","journal-title":"Neurorehabil Neural Repair"},{"issue":"6","key":"5210_CR229","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/HTR.0b013e318270f91e","volume":"27","author":"JB Cantor","year":"2012","unstructured":"Cantor JB et al (2012) Insomnia, fatigue, and sleepiness in the first 2 years after traumatic brain injury: an NIDRR TBI model system module study. J Head Trauma Rehabil 27(6):E1-14","journal-title":"J Head Trauma Rehabil"},{"issue":"5","key":"5210_CR230","first-page":"e38479","volume":"15","author":"F Ali","year":"2023","unstructured":"Ali F et al (2023) Chronic refractory insomnia in a patient with undiagnosed bipolar disorder and long-standing traumatic brain injury. Cureus 15(5):e38479","journal-title":"Cureus"},{"issue":"1","key":"5210_CR231","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/neu.2017.5450","volume":"36","author":"Z Zhang","year":"2018","unstructured":"Zhang Z et al (2018) Traumatic injury leads to inflammation and altered tryptophan metabolism in the juvenile rabbit brain. Journal of Neurotrauma 36(1):74\u201386","journal-title":"J Neurotrauma"},{"key":"5210_CR232","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.bbi.2020.03.002","volume":"87","author":"TB Meier","year":"2020","unstructured":"Meier TB et al (2020) Prospective study of the effects of sport-related concussion on serum kynurenine pathway metabolites. Brain, Behavior, and Immunity 87:715\u2013724","journal-title":"Brain Behav Immun"},{"key":"5210_CR233","doi-asserted-by":"crossref","first-page":"1210453","DOI":"10.3389\/fneur.2023.1210453","volume":"14","author":"M Dehhaghi","year":"2023","unstructured":"Dehhaghi M, Heng B, Guillemin GJ (2023) The kynurenine pathway in traumatic brain injuries and concussion. Front Neurol 14:1210453","journal-title":"Front Neurol"},{"issue":"1","key":"5210_CR234","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1468-1331.2006.01220.x","volume":"13","author":"GM Mackay","year":"2006","unstructured":"Mackay GM et al (2006) Tryptophan metabolism and oxidative stress in patients with chronic brain injury. European Journal of Neurology 13(1):30\u201342","journal-title":"Eur J Neurol"},{"issue":"9","key":"5210_CR235","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1111\/jnc.16137","volume":"168","author":"K Visser","year":"2024","unstructured":"Visser K et al (2024) Exploring the kynurenine pathway in mild traumatic brain injury: a longitudinal study. Journal of Neurochemistry 168(9):2710\u20132721","journal-title":"J Neurochem"},{"key":"5210_CR236","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12974-015-0328-2","volume":"12","author":"EB Yan","year":"2015","unstructured":"Yan EB et al (2015) Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans. J Neuroinflammation 12:110","journal-title":"J Neuroinflammation"},{"issue":"6","key":"5210_CR237","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/jnnp-2015-311369","volume":"87","author":"R Singh","year":"2016","unstructured":"Singh R et al (2016) Mood symptoms correlate with kynurenine pathway metabolites following sports-related concussion. Journal of Neurology, Neurosurgery & Psychiatry 87(6):670\u2013675","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"5210_CR238","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00004647-199806000-00002","volume":"18","author":"EH Sinz","year":"1998","unstructured":"Sinz EH et al (1998) Quinolinic acid is increased in CSF and associated with mortality after traumatic brain injury in humans. J Cereb Blood Flow Metab 18(6):610\u20135","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"5210_CR239","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.biopsych.2021.05.021","volume":"91","author":"TB Meier","year":"2022","unstructured":"Meier TB, Savitz J (2022) The kynurenine pathway in traumatic brain injury: implications for psychiatric outcomes. Biological Psychiatry 91(5):449\u2013458","journal-title":"Biol Psychiatry"},{"key":"5210_CR240","doi-asserted-by":"crossref","unstructured":"Mangas A et al (2018) Overexpression of kynurenic acid and 3-hydroxyanthranilic acid after rat traumatic brain injury. Eur J Histochem 62(4):2985","DOI":"10.4081\/ejh.2018.2985"},{"key":"5210_CR241","doi-asserted-by":"crossref","unstructured":"Zhang Y, Wang L, Ren W (2022) Blast-related traumatic brain injury is mediated by the kynurenine pathway. NeuroReport 33(13):569\u2013576","DOI":"10.1097\/WNR.0000000000001817"},{"issue":"11","key":"5210_CR242","doi-asserted-by":"crossref","first-page":"166491","DOI":"10.1016\/j.bbadis.2022.166491","volume":"1868","author":"NM Mercado","year":"2022","unstructured":"Mercado NM et al (2022) Traumatic brain injury alters the gut-derived serotonergic system and associated peripheral organs. Biochim Biophys Acta Mol Basis Dis 1868(11):166491","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"5210_CR243","doi-asserted-by":"publisher","unstructured":"Badyal P, Kaur J, Kuhad A (2021) Role of 5-HT in Cerebral Edema after Traumatic Brain Injury. IntechOpen. Available at: https:\/\/doi.org\/10.5772\/intechopen.96460","DOI":"10.5772\/intechopen.96460"},{"issue":"4","key":"5210_CR244","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/01616412.2015.1110402","volume":"38","author":"K Abe","year":"2016","unstructured":"Abe K et al (2016) Traumatic brain injury decreases serotonin transporter expression in the rat cerebrum. Neurol Res 38(4):358\u201363","journal-title":"Neurol Res"},{"issue":"6","key":"5210_CR245","first-page":"100966","volume":"40","author":"L Lorente","year":"2021","unstructured":"Lorente L et al (2021) Serum melatonin levels in predicting mortality in patients with severe traumatic brain injury. Anaesth Crit Care Pain Med 40(6):100966","journal-title":"Anaesth Crit Care Pain Med"},{"key":"5210_CR246","doi-asserted-by":"crossref","unstructured":"Marseglia L et al (2017) Melatonin secretion is increased in children with severe traumatic brain injury. Int J Mol Sci 18(5):1053","DOI":"10.3390\/ijms18051053"},{"key":"5210_CR247","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fneur.2014.00237","volume":"5","author":"MA Seifman","year":"2014","unstructured":"Seifman MA et al (2014) Measurement of serum melatonin in intensive care unit patients: changes in traumatic brain injury, trauma, and medical conditions. Front Neurol 5:237","journal-title":"Front Neurol"},{"key":"5210_CR248","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2014.04.031","volume":"73","author":"K Ding","year":"2014","unstructured":"Ding K et al (2014) Melatonin stimulates antioxidant enzymes and reduces oxidative stress in experimental traumatic brain injury: the Nrf2-ARE signaling pathway as a potential mechanism. Free Radic Biol Med 73:1\u201311","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"5210_CR249","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1530\/JOE-13-0022","volume":"217","author":"M Campolo","year":"2013","unstructured":"Campolo M et al (2013) Combination therapy with melatonin and dexamethasone in a mouse model of traumatic brain injury. J Endocrinol 217(3):291\u2013301","journal-title":"J Endocrinol"},{"issue":"4","key":"5210_CR250","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/neu.2018.5752","volume":"36","author":"KM Barlow","year":"2019","unstructured":"Barlow KM et al (2019) Melatonin as a treatment after traumatic brain injury: a systematic review and meta-analysis of the pre-clinical and clinical literature. J Neurotrauma 36(4):523\u2013537","journal-title":"J Neurotrauma"},{"issue":"3","key":"5210_CR251","first-page":"38","volume":"100","author":"M Rosenblum","year":"2017","unstructured":"Rosenblum M (2017) Substance abuse and insomnia. Minn Med 100(3):38\u201339","journal-title":"Minn Med"},{"issue":"4","key":"5210_CR252","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.psc.2015.07.008","volume":"38","author":"TA Roehrs","year":"2015","unstructured":"Roehrs TA, Roth T (2015) Sleep disturbance in substance use disorders. Psychiatr Clin North Am 38(4):793\u2013803","journal-title":"Psychiatr Clin North Am"},{"key":"5210_CR253","doi-asserted-by":"crossref","unstructured":"Davidson M et al (2023) Tryptophan and substance abuse: mechanisms and impact. Int J Mol Sci 24(3):2737","DOI":"10.3390\/ijms24032737"},{"key":"5210_CR254","doi-asserted-by":"crossref","unstructured":"Contella L et al (2024) Impact of Substance use disorder on tryptophan metabolism through the kynurenine pathway: a narrative review. Metabolites 14(11):611","DOI":"10.3390\/metabo14110611"},{"key":"5210_CR255","doi-asserted-by":"crossref","first-page":"110821","DOI":"10.1016\/j.drugalcdep.2023.110821","volume":"249","author":"Z Wang","year":"2023","unstructured":"Wang Z et al (2023) Kynurenine metabolite changes in individuals with alcohol use disorder: a systematic review and meta-analysis. Drug Alcohol Depend 249:110821","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"5210_CR256","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1079\/NRR200133","volume":"15","author":"AA Badawy","year":"2002","unstructured":"Badawy AA (2002) Tryptophan metabolism in alcoholism. Nutr Res Rev 15(1):123\u201352","journal-title":"Nutr Res Rev"},{"issue":"1","key":"5210_CR257","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/cbm.529","volume":"13","author":"AAB Badawy","year":"2003","unstructured":"Badawy AAB (2003) Alcohol and violence and the possible role of serotonin. Criminal Behaviour and Mental Health 13(1):31\u201344","journal-title":"Crim Behav Ment Health"},{"key":"5210_CR258","doi-asserted-by":"crossref","unstructured":"Sontate KV et al (2021) Alcohol, aggression, and violence: from public health to neuroscience. Front Psychol 12:699726","DOI":"10.3389\/fpsyg.2021.699726"},{"key":"5210_CR259","doi-asserted-by":"crossref","unstructured":"Vidal R et al (2020) Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity. Prog Neuro-Psychopharmacol Biol Psychiatry 102:109958","DOI":"10.1016\/j.pnpbp.2020.109958"},{"key":"5210_CR260","doi-asserted-by":"crossref","unstructured":"Leclercq S et al (2021) Alterations of kynurenine pathway in alcohol use disorder and abstinence: a link with gut microbiota, peripheral inflammation and psychological symptoms. Transl Psychiatry 11(1):503","DOI":"10.1038\/s41398-021-01610-5"},{"key":"5210_CR261","doi-asserted-by":"crossref","first-page":"109831","DOI":"10.1016\/j.pnpbp.2019.109831","volume":"99","author":"M Meyrel","year":"2020","unstructured":"Meyrel M, Rolland B, Geoffroy PA (2020) Alterations in circadian rhythms following alcohol use: a systematic review. Progress in Neuro-Psychopharmacology and Biological Psychiatry 99:109831","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1","key":"5210_CR262","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bja.2019.08.010","volume":"124","author":"BA Baldo","year":"2020","unstructured":"Baldo BA, Rose MA (2020) The anaesthetist, opioid analgesic drugs, and serotonin toxicity: a mechanistic and clinical review. British Journal of Anaesthesia 124(1):44\u201362","journal-title":"Br J Anaesth"},{"issue":"2","key":"5210_CR263","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/biom10020284","volume":"10","author":"E Sz\u0171cs","year":"2020","unstructured":"Sz\u0171cs E et al (2020) Discovery of kynurenines containing oligopeptides as potent opioid receptor agonists. Biomolecules 10(2):284","journal-title":"Biomolecules"},{"issue":"9","key":"5210_CR264","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.2174\/1871527314666141205164114","volume":"13","author":"F Z\u00e1dor","year":"2014","unstructured":"Z\u00e1dor F et al (2014) Inhibition of opioid receptor mediated G-protein activity after chronic administration of kynurenic acid and its derivative without direct binding to opioid receptors. CNS & neurological disorders drug targets 13(9):1520\u20139","journal-title":"CNS Neurol Dis Drug Targets"},{"key":"5210_CR265","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuropharm.2014.02.019","volume":"82","author":"S Beggiato","year":"2014","unstructured":"Beggiato S et al (2014) Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex. Neuropharmacology 82:11\u201318","journal-title":"Neuropharmacology"},{"issue":"1","key":"5210_CR266","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/jnc.14043","volume":"142","author":"A Eskelund","year":"2017","unstructured":"Eskelund A et al (2017) Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression-like behavior. J Neurochem 142(1):118\u2013131","journal-title":"J Neurochem"},{"key":"5210_CR267","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jpsychires.2015.04.026","volume":"66\u201367","author":"A Halaris","year":"2015","unstructured":"Halaris A et al (2015) Does escitalopram reduce neurotoxicity in major depression? J Psychiatr Res 66\u201367:118\u201326","journal-title":"J Psychiatr Res"},{"key":"5210_CR268","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbi.2020.01.011","volume":"87","author":"Y Sun","year":"2020","unstructured":"Sun Y et al (2020) The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine. Brain Behav Immun 87:404\u2013412","journal-title":"Brain Behav Immun"},{"key":"5210_CR269","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3389\/fimmu.2019.01801","volume":"10","author":"J Gunther","year":"2019","unstructured":"Gunther J, Dabritz J, Wirthgen E (2019) Limitations and off-target effects of tryptophan-related IDO inhibitors in cancer treatment. Front Immunol 10:1801","journal-title":"Front Immunol"},{"issue":"2","key":"5210_CR270","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1097\/MJT.0000000000000584","volume":"25","author":"JN Losso","year":"2018","unstructured":"Losso JN et al (2018) Pilot study of the tart cherry juice for the treatment of insomnia and investigation of mechanisms. Am J Ther 25(2):e194\u2013e201","journal-title":"Am J Ther"},{"key":"5210_CR271","doi-asserted-by":"crossref","unstructured":"Sutcliffe TC et al (2017) Procyanidin B2 protects neurons from oxidative, nitrosative, and excitotoxic stress. Antioxidants (Basel) 6(4):77","DOI":"10.3390\/antiox6040077"},{"key":"5210_CR272","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3389\/fphar.2019.01044","volume":"10","author":"E Fertan","year":"2019","unstructured":"Fertan E et al (2019) Effects of the novel IDO inhibitor DWG-1036 on the behavior of male and female 3xTg-AD mice. Front Pharmacol 10:1044","journal-title":"Front Pharmacol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05210-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05210-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05210-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:10:40Z","timestamp":1761909040000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05210-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":272,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["5210"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05210-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}]}}